Article
Polymorphism of the ATM-gene seems to have no major impact on the risk for a breast cancer disease
Search Medline for
Authors
Published: | March 20, 2006 |
---|
Outline
Text
Introduction: The ATM-Gene plays a key role in DNA-repair and several models of carcinogenesis. The ATM-product interacts with several oncogenic and tumor-suppressive proteins like p53, Rb, E2F or cyclines. A genetic variation at the gene encoding for ATM may be associated with an altered breast cancer risk. Aim of this study was to assess the association of ATM-polymorphisms with the risk for a breast cancer disease.
Methods: Subjects were obtained from the Erlangen Breast Cancer Association Study Subjects were 196 histologically confirmed breast cancer patients and 385 non-hospital controls without cancer. Polymorphism d1853v (rs1801673) of the ATM-gene was analyzed by RT-PCR with the ABIPrism7000®. Odds ratios (OR) and 95% confidence intervals (95% CI) were determined by logistic regression analysis.
Results: The frequency among controls was 73,0% for the A/A genotype, 26% for the A/T genotype and 1% for the T/T genotype. The breast cancer cases showed an a distribution of 73% (A/A), 25,5% (A/T) and 1,5% (T/T). No association was found for each genotype (p=0,875).
Conclusion: In our study no association between breast cancer risk and a polymorphism of the ATM-gene could be found. Concerning the rare T/T genotype there was a non-significant increase for the breast cancer risk. The complete analysis of the whole sample (n=985) of the Erlangen Breast Cancer Association Study will be presented at the congress.